Mixed
Bariatric surgery provides superior weight loss and type 2 diabetes remission compared to non-surgical treatments across all obesity severities and follow-up durations.
For individuals with obesity (BMI > 30) who have not achieved sustained results with lifestyle changes, bariatric surgery is clinically superior to non-surgical methods for achieving significant weight loss and remission of type 2 diabetes, regardless of how severe the obesity is or how long the follow-up period is.
The pooled results of primary endpoints (weight loss and diabetic remission) revealed a significant advantage among surgical patients rather than those receiving non-surgical treatments (P < 0.05).
Why this rating
Systematic review and meta-analysis of 25 RCTs, though publication bias was noted.
Source
The comprehensive summary of surgical versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomized controlled trials
Ji Cheng et al. · Oncotarget · 2016
DOI 10.18632/oncotarget.9581
More from this paper
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →